Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Shaw

Showing results (21-30 of 449) with videos related to

Pageof 45
Sort By:
Nature Reviews. Endocrinology|June 6, 2022
The burden and risks of emerging complications of diabetes mellitusDunya Tomic, Jonathan E Shaw, Dianna J Magliano
The Medical Journal of Australia|July 7, 2011
Is Australia ready to use glycated haemoglobin for the diagnosis of diabetes?Jonathan E Shaw, Michael C d'Emden, Ian Goodall
International Journal of Epidemiology|June 12, 2016
Lipidomic analyses in epidemiologyPiyushkumar A Mundra, Jonathan E Shaw, Peter J Meikle
Diabetes Care|September 22, 2020
Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes TrialsJulian W Sacre, Dianna J Magliano, Jonathan E Shaw
Diabetes Research and Clinical Practice|February 20, 2017
Diabetes and disability in older Australians: The Australian Diabetes, Obesity and Lifestyle (AusDiab) studyDigsu N Koye, Jonathan E Shaw, Dianna J Magliano
Diabetic Medicine : a Journal of the British Diabetic Association|August 8, 2024
Trends in rates of hospitalisation for infection in people with diabetes and the general populationBerhanu Elfu Feleke, Jonathan E Shaw, Dianna J Magliano
Annals of Medicine|February 2, 2006
How to best define the metabolic syndromeDianna J Magliano, Jonathan E Shaw, Paul Z Zimmet
The Medical Journal of Australia|July 22, 2014
Linking data to improve health outcomesJessica L Harding, Jonathan E Shaw, Dianna J Magliano
Diabetes & Metabolism|March 21, 2021
Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trialsJulian W Sacre, Dianna J Magliano, Jonathan E Shaw
Diabetes Care|July 1, 2022
Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor TherapyJulian W Sacre, Dianna J Magliano, Jonathan E Shaw
Pageof 45

Showing results (21-30 of 449) with videos related to

Sort By:
Pageof 45
Nature Reviews. Endocrinology|June 6, 2022
The burden and risks of emerging complications of diabetes mellitusDunya Tomic, Jonathan E Shaw, Dianna J Magliano
The Medical Journal of Australia|July 7, 2011
Is Australia ready to use glycated haemoglobin for the diagnosis of diabetes?Jonathan E Shaw, Michael C d'Emden, Ian Goodall
International Journal of Epidemiology|June 12, 2016
Lipidomic analyses in epidemiologyPiyushkumar A Mundra, Jonathan E Shaw, Peter J Meikle
Diabetes Care|September 22, 2020
Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes TrialsJulian W Sacre, Dianna J Magliano, Jonathan E Shaw
Diabetes Research and Clinical Practice|February 20, 2017
Diabetes and disability in older Australians: The Australian Diabetes, Obesity and Lifestyle (AusDiab) studyDigsu N Koye, Jonathan E Shaw, Dianna J Magliano
Diabetic Medicine : a Journal of the British Diabetic Association|August 8, 2024
Trends in rates of hospitalisation for infection in people with diabetes and the general populationBerhanu Elfu Feleke, Jonathan E Shaw, Dianna J Magliano
Annals of Medicine|February 2, 2006
How to best define the metabolic syndromeDianna J Magliano, Jonathan E Shaw, Paul Z Zimmet
The Medical Journal of Australia|July 22, 2014
Linking data to improve health outcomesJessica L Harding, Jonathan E Shaw, Dianna J Magliano
Diabetes & Metabolism|March 21, 2021
Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trialsJulian W Sacre, Dianna J Magliano, Jonathan E Shaw
Diabetes Care|July 1, 2022
Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor TherapyJulian W Sacre, Dianna J Magliano, Jonathan E Shaw
Pageof 45